UNH remains a solid business with a great potential upside. The recent drop was driven by softer financials, CEO resignation, and a DOJ probe—more fear than fundamentals.
Core operations are stable. Valuation is now attractive, making this a solid entry point for patient investors.
Many argue that UNH is just an insurance business, not a tech company. They are wrong. UNH holds a massive amount of healthcare data that can be leveraged for insights, efficiency, and innovation. This data is not just an asset—it is a moat that few competitors can replicate.
The recent insider buying is a green flag ! a signal for investors that there are no skelatons in the closet
On the chart, increasing green volume supports bullish sentiment. The 10-day EMA has crossed above the 20-day EMA on the hourly timeframe, indicating short-term upward momentum. Additionally, the MACD is turning positive indicating less fear and more greed!, and RSI is trending higher—both pointing to strengthening buying pressure.
Core operations are stable. Valuation is now attractive, making this a solid entry point for patient investors.
Many argue that UNH is just an insurance business, not a tech company. They are wrong. UNH holds a massive amount of healthcare data that can be leveraged for insights, efficiency, and innovation. This data is not just an asset—it is a moat that few competitors can replicate.
The recent insider buying is a green flag ! a signal for investors that there are no skelatons in the closet
On the chart, increasing green volume supports bullish sentiment. The 10-day EMA has crossed above the 20-day EMA on the hourly timeframe, indicating short-term upward momentum. Additionally, the MACD is turning positive indicating less fear and more greed!, and RSI is trending higher—both pointing to strengthening buying pressure.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.